Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: results from an open‐label extension study
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 62
(10)
◽
pp. 1499-1510
◽
Keyword(s):
2003 ◽
Vol 13
◽
pp. S388-S389
◽
Keyword(s):
2019 ◽
Vol 407
◽
pp. 116419
◽
Keyword(s):
Keyword(s):
Keyword(s):